C&R Research Inc. (KOSDAQ:359090)
South Korea
· Delayed Price · Currency is KRW 777.00
-2.00 (-0.26%)
At close: Apr 29, 2026
C&R Research Revenue
In the year 2025, C&R Research had annual revenue of 64.98B KRW with 8.87% growth. C&R Research had revenue of 15.21B in the quarter ending December 31, 2025, with 7.11% growth.
Revenue
64.98B
Revenue Growth
+8.87%
P/S Ratio
0.69
Revenue / Employee
127.42M
Employees
510
Market Cap
44.77B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DT&CRO CO. | 47.75B |
| WOOJUNG BIO | 37.59B |
| P&K Skin Research Center | 22.78B |
| SLS BIO | 3.98B |
| BioInfra | 23.15B |
| HLB bioStep | 74.05B |
| DreamCIS | 66.63B |
| Curachem | 6.02B |